Latest filing published 07 Jun 2023 for Pacira BioSciences, Inc., €41k.
Filing timeline
BuySaleInsider track record
Ronald J. Ellis Jr.: trading record in brief
Ronald J. Ellis Jr. has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Pacira BioSciences, Inc. and TELA Bio, Inc. Between 13 November 2019 and 7 June 2023, the trades on record add up to 3 filings.
On the market, this insider has only sold: 2 sales, €82k in total. So far in 2023, the count stands at no purchases and 2 sales.
The newest entry dates from 7 June 2023: an open-market sale of €41k, in Pacira BioSciences, Inc. Publication is fast: at least half of the trades appear on SEC (Form 4) on the same day. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Ronald J. Ellis Jr.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,162 shares@ US$37.8750.3% of flowCommon StockSEC:0001209191-23-035255:1
- 1,114 shares@ US$38.991100.0% of flowCommon StockSEC:0001209191-23-035255:0
- 580,357 sharesCommon StockSEC:0001192482-19-000432:0
3 of 3 declarations
